FindTrial
Sign In

Understanding Public Preferences and Willingness to Pay for an Mpox (previously called monkey pox) Vaccine in South India: A Survey

Key Decisions in a Global Health Crisis: Assessing Demand, preferences and willingness to Pay for a Hypothetical Mpox Vaccine through a south-Indian Discrete Choice Experiment - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/12/078355
Enrollment
2000
Registered
2024-12-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Kasturba Medical College Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All consenting adults of any biological sex, age 18 years and above 2. A citizen of India who has been residing in South India. 3. Have not stayed outside of India for more than 3 months in the last 6 months

Exclusion criteria

Exclusion criteria: 1. Non-resident Indians (NRIs) and overseas citizen of India (OCIs) [despite having a Passport or dual citizenship] 2. Those who do not answer the trap question correctly 3. Those who have language or technical barriers in using a digital media 4. Incompletely filled survey forms [anything less than 100 percent] The trap question would be a repeat of one of the previous questions. Any discordance in the answer option chosen will be considered as failed.

Design outcomes

Primary

MeasureTime frame
Preferred characteristics of a Mpox vaccine Timepoint: Baseline—

Secondary

MeasureTime frame
Prevalence of vaccine hesitancy and its predictors Willingness to payTimepoint: Baseline—

Countries

India

Contacts

Public ContactDr Jeffrey Pradeep Raj

Kasturba Medical College Manipal

jpraj.m07@gmail.com08095464464

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026